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A large number of hypothetical genes potentially encoding small proteins of unknown
function are annotated in the Brucella abortus genome. Individual deletion of 30 of these
genes identified four mutants, in BAB1_0355, BAB2_0726, BAB2_0470, and BAB2_0450
that were highly attenuated for infection. BAB2_0726, an YbgT-family protein located at the
3′ end of the cydAB genes encoding cytochrome bd ubiquinal oxidase, was designated
cydX. A B. abortus cydX mutant lacked cytochrome bd oxidase activity, as shown by
increased sensitivity to H2O2, decreased acid tolerance and increased resistance to killing
by respiratory inhibitors. The C terminus, but not the N terminus, of CydX was located
in the periplasm, suggesting that CydX is an integral cytoplasmic membrane protein.
Phenotypic analysis of the cydX mutant, therefore, suggested that CydX is required for
full function of cytochrome bd oxidase, possibly via regulation of its assembly or activity.
Keywords: cytochrome oxidase, terminal electron acceptor, mutant screen, peptide
INTRODUCTION
Genes encoding small proteins are not well-characterized in the
genomes of bacteria. An examination of the sequenced genomes
shows that these small genes are not consistently annotated
across related genomes, which raises the question of whether
they encode functional genes. Further, the small size of the
coding genes reduces the probability of identifying their func-
tions in transposon mutagenesis screens. In bacteria, relatively
few small proteins have been characterized. These include the
toxin peptides of toxin/antitoxin systems, which insert into mem-
branes and cause damage (Gerdes et al., 1986), and peptides that
functions as “connectors” of two-component signal transduc-
tion systems (Eguchi et al., 2011). Recent studies in Escherichia
coli and Salmonella enterica serovar Typhimurium have iden-
tified several small proteins whose expression had previously
been overlooked in proteomic and genomic studies (Alix and
Blanc-Potard, 2009; Hemm et al., 2010). One of these proteins,
MgtR, modulates degradation of MgtC, a cytoplasmic protein
involved in replication of S. typhimurium within host cells, by
the FtsH protease, suggesting a role for MgtR in adaptation to
the host environment (Alix and Blanc-Potard, 2008). A second
peptide found to target the activity of FtsH protease, SpoVM,
has been identified in Bacillus subtilis (Cutting et al., 1997). In
Agrobacterium tumefaciens, a close phylogenetic relative of the
Brucella species, a small protein VirE1 has been shown to serve
as a secretion chaperone for the Type IV-exported single-strand
binding protein VirE2 (Deng et al., 1999). Given their potential
role in virulence-associated functions, we determined the role in
intracellular survival of 30 genes with the potential to encode pro-
teins of <15 kDa in the intracellular pathogen Brucella abortus.
One of the proteins identified in this screen, BAB2_0726, was
encoded in the 3′ region of cydAB, encoding cytochrome bd oxi-
dase. This terminal oxidase of the respiratory chain is expressed
by B. suis inside macrophages, the preferred intracellular niche
in vivo (Loisel-Meyer et al., 2005), and contributes to intracel-
lular replication of B. abortus, B. suis, and B. melitensis (Endley
et al., 2001; Loisel-Meyer et al., 2005; Wu et al., 2006). We, there-
fore, focused our efforts on the contribution of BAB2_0726 to the
function of cytochrome bd oxidase.
MATERIALS AND METHODS
BACTERIAL STRAINS, MEDIA, AND CULTURE CONDITIONS
Escherichia coli TOP10 cells were used for all cloning steps
and transformation of PCR products cloned into the pCR2.1
TOPO vector (Invitrogen). All E. coli strains were grown
in Luria-Bertani (LB) broth. Antibiotics carbenicillin (Carb)
100μg/ml, kanamycin (Kan), 100μg/ml or chloramphenicol
(Cm), 30μg/ml were used as appropriate. Brucella abortus biovar
1 strain 2308, a virulent strain originally isolated from cattle, was
used for generation of mutants. Bacterial inocula used for infec-
tion of mice were cultured on tryptic soy agar (TSA) plus 5%
defibrinated sheep blood. The antibiotics Carb 100μg/ml, Kan,
50μg/ml; Cm, 15μg/ml were added as needed. All work with live
B. abortuswas performed at biosafety level 3. Bacterial strains and
plasmids used in this study are listed in Table 1.
ALLELIC EXCHANGE MUTAGENESIS
A previously reported three-step cloning strategy (Sun et al.,
2005) was used to construct mutants for small open reading
frames (Figure A1). Briefly, an upstream fragment (with a SmaI
site in reverse primer) and a downstream fragment (with a SmaI
site in forward primer and a PstI site in reverse primer), both
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Table 1 | Strains and plasmids used in this work.
Strain or plasmid Description Reference or source
PLASMIDS
pCR2.1 PCR TOPO cloning vector Invitrogen
pUC4Kixx 1.3 Kb Kan cassette as SmaI fragment, AmpR, KanR Pharmarcia
pBBR1MCS4 Broad-host range vector confers AmpR Kovach et al., 1995
pFlagTEM1 Cloning vector to express flagged TEM1 (FT) fusion under control of trc promoter, CmR Raffatellu et al., 2005
pCydX/FT Expresses CydX::FT from trc promoter, CmR This study
pFT/CydX Expresses FT::CydX from trc promoter, CmR This study
pGST/FT Expresses GST::FT from trc promoter, CmR Raffatellu et al., 2005
pFT/GST Expresses FT::GST fromtrc promoter, CmR de Jong et al., 2008
pGroEL/dsRed Expresses DsRed from Brucella GroEL promoter, CmR This study
pGroEL/CydX Expresses CydX from Brucella GroEL promoter, CmR This study
pGroEL/CydB Expresses CydB from Brucella GroEL promoter, CmR This study
pGroEL/CydBX Expresses CydBX from Brucella GroEL promoter, CmR This study
pBBR1Flag Cloning vector to express flagged fusion under Brucella constitutive promoter, CmR This study
pCydX/Flag Expresses CydX::Flag from Brucella constitutive promoter, CmR This study
BRUCELLA
B. abortus 2308 Wild type
ADH3 virB2 (non polar) in B. abortus 2308 den Hartigh et al., 2004
BA41 virB1::Tn5 in B. abortus 2308 Hong et al., 2000
BA582 cydB::Tn5 in B. abortus 2308 Endley et al., 2001
BAB1_0061::Kan in B. abortus 2308 This study
BAB1_0355::Kan in B. abortus 2308 This study
BAB1_0513::Kan in B. abortus 2308 This study
BAB1_0581::Kan in B. abortus 2308 This study
BAB1_0626::Kan in B. abortus 2308 This study
BAB1_0743::Kan in B. abortus 2308 This study
BAB1_0992::Kan in B. abortus 2308 This study
BAB1_1106::Kan in B. abortus 2308 This study
BAB1_1194::Kan in B. abortus 2308 This study
BAB1_1204::Kan in B. abortus 2308 This study
BAB1_1262::Kan in B. abortus 2308 This study
BAB1_1390::Kan in B. abortus 2308 This study
BAB1_1392::Kan in B. abortus 2308 This study
BAB1_1743::Kan in B. abortus 2308 This study
BAB1_1748::Kan in B. abortus 2308 This study
BAB1_1939::Kan in B. abortus 2308 This study
BAB1_2041::Kan in B. abortus 2308 This study
BAB2_0160::Kan in B. abortus 2308 This study
BAB2_0170::Kan in B. abortus 2308 This study
BAB2_0862::Kan in B. abortus 2308 This study
BAB2_0761::Kan in B. abortus 2308 This study
BAB2_0726::Kan in B. abortus 2308 (cydX::Kan) This study
BAB2_0470::Kan in B. abortus 2308 This study
BAB2_0450::Kan in B. abortus 2308 This study
BAB2_0415::Kan in B. abortus 2308 This study
BAB2_0400::Kan in B. abortus 2308 This study
BAB2_0232::Kan in B. abortus 2308 This study
BAB2_1072::Kan in B. abortus 2308 This study
BAB2_1087::Kan in B. abortus 2308 This study
BAB2_1036::Kan in B. abortus 2308 This study
B. abortus 2308 with pCydX/Flag This study
B. abortus 2308 with pBBR1MCS4 This study
B. abortus 2308 with pFlagTEM1 de Jong et al., 2008
(Continued)
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Table 1 | Continued
Strain or plasmid Description Reference or source
B. abortus 2308 with pCydX/FT This study
B. abortus 2308 with pFT/CydX This study
B. abortus 2308 with pGST/FT This study
B. abortus 2308 with pFT/GST de Jong et al., 2008
cydX::Kan with pGroEL/dsRed This study
cydX::Kan with pGroEL/CydX This study
cydX::Kan with pCydX/Flag This study
BA582 with pGroEL/CydX This study
BA582 with pGroEL/CydB This study
BA582 with pGroEL/CydBX This study
measuring about 600–1200 bp, were amplified and cloned in
pCR2.1. The orientation of the upstream fragment was deter-
mined by PCR using one primer specific for the insert and one
primer specific for the vector (for example T7 promoter primer)
to identify a clone with the SmaI site located at the f1 ori-
gin end of the multiple cloning site in TOPO cloning vector
pCR2.1. The SmaI/PstI digested downstream fragment was then
cloned next to the upstream fragment by using ampicillin for
selection marker since the SmaI/PstI double digestion of vec-
tor cleaves a 1.2 Kb fragment from pCR2.1 backbone including
part of kanamycin resistance gene. A 1.3 Kb SmaI fragment of
pUC4KIXX (Pharmacia) containing the Tn5 kanamycin resis-
tance gene was then cloned into the SmaI site to generate
a construct for the allelic exchange of candidate gene with a
deleted copy replaced by a kanamycin resistance gene. These plas-
mids were introduced into B. abortus 2308 by electroporation.
Recombinants were screened for kanamycin resistance and car-
benicillin sensitivity. Deletion of target genes was confirmed by
PCR or/and southern blot.
RNA PREPARATION AND RT-PCR
B. abortus strains were grown for 48 h in tryptic soy broth (TSB)
in parafilm-sealed tubes with minimal headspace to limit oxy-
gen availability. The cells were harvested by centrifugation at
5000 × g. Total RNA was isolated using the Aurum Mini Kit
(Bio-rad). RNA samples were digested with RNase-free DNase I
(Invitrogen) and quantified using a NanoDrop spectrophome-
ter (Thermo Scientific) at 260/280 nm. Reverse transcription
was carried out using a standard protocol and MMLV Reverse
Transcriptase (Invitrogen). Primer pairs used to amplify cydA
(247 bp), cydB (243 bp), and cydX (204 bp) are listed in Table A1.
PCR primers (2μM) and cDNAs were added in PCR SuperMix
(Invitrogen), and heated to 95◦C for 5min. Reactions omitting
the reverse transcriptase served as negative controls. The PCR
cycle consisted of 94◦C for 10 s (denaturation), 52–55◦C for 30 s
(annealing), and 72◦C for 10 s (extension), and this was repeated
30 times. PCR products were visualized after agarose gel (1.4%)
electrophoresis and SYBR staining (Invitrogen).
MACROPHAGE KILLING ASSAY
The mouse macrophage-like cell line J774A.1, obtained from
ATCC, was cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM; Gibco, Rockville, MD) supplemented with 10% heat-
inactivated fetal bovine serum, 1%non-essential amino acids, and
1mM Glutamine (DMEMsup). For macrophage killing assays,
24-well microtiter dishes were seeded with macrophages at a
concentration of 1–2 ×105 cells/well in 0.5ml of DMEMsup and
incubated over night at 37◦C in 5% CO2. Inocula were prepared
by growth with shaking in TSB for 24 h, then subsequent dilu-
tion in DMEMsup to a concentration of 4 × 107 colony-forming
units (CFU)/ml. Approximately 2× 107 bacteria in 0.5ml of
DMEMsup, containing single or a 1:1 mixture of wild type
and mutant, were added to each well of macrophages.Microtiter
dishes were centrifuged at 250 × g for 5min at room tempera-
ture in order to synchronize infection. Cells were incubated for
20min at 37◦C in 5% CO2, free bacteria were removed by three
washes with phosphate-buffered saline (PBS). DMEMsup plus
50μg gentamicin per ml was added to the wells, and the cells
were incubated at 37◦C in 5% CO2. After 1 h, the DMEMsup
plus 50μg/ml gentamicin was replaced with medium containing
25μg/ml gentamicin. Wells were sampled at 48 h after infection
by aspirating the medium, lysing the macrophages with 0.5ml of
0.5% Tween-20 and rinsing each well with 0.5ml of PBS. Viable
bacteria were quantified by dilution in sterile PBS and plat-
ing on TSA or/and TSA + Kan. Competitive Index, which were
adjustedby inoculaCFU,were calculated asMutantCFU/WTCFU
per well.
COMPETITIVE INFECTION IN MICE
Female BALB/c ByJ mice were obtained from the Jackson
Laboratory (Bar Harbor, ME) and used at an age of 6–10
weeks. For mixed infection experiments, groups of 2–5 mice
were inoculated intraperitoneally with 0.5ml of PBS containing
2 × 105 CFU of a 1:1 mixture of B. abortus wild type and the
isogenic mutant. Infected mice were held in microisolator cages
in a Biosafety Level 3 facility. At four weeks post-infection, mice
were euthanized by CO2 asphyxiation and the spleens were col-
lected aseptically at necropsy. Spleens were homogenized in 3ml
of PBS and serial dilutions of the homogenate plated on TSA and
TSA containing kanamycin, for enumeration of mutant and wild
type CFU. Competitive Index was calculated as Mutant CFU/WT
CFU recovered from the spleen divided byMutant CFU/WT CFU
in the inoculum. Animal experiments were approved by the UC
Davis Institutional Animal Care and Use Committee.
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ASSAY FOR LOSS OF STATIONARY PHASE VIABILITY
B. abortus cells, freshly re-suspended from TSA plates, were
washed once with PBS and diluted into 5ml TSB or modified
minimal E-medium (Kulakov et al., 1997) pH 7.0 with starting
OD600 = 0.01. Bacteria were grown in a shaking incubator at
optimal condition of 200 rpm, 37◦C, and 5% CO2. At time points
up to seven days bacterial CFU were enumerated by serial dilu-
tion and plating on TSA. Loss of viability during stationary phase
was defined as a reduction in bacterial numbers after 72 h incuba-
tion. Experiments were repeated at least three times and produced
similar results. Results of a representative experiment are shown.
ACID TOLERANCE TEST
After 24 h of growth in E-medium pH 7.0, bacteria were washed
once with PBS and re-suspended in the same volume of E-
medium adjusted to pH 7.0, or to pH 5.0 or 3.5 with 1M Citric
Acid. After 5 h incubation, CFU were determined by serial dilut-
ing and plating on TSA. Acid tolerance was measured by com-
paring growth at pH 3.5 or 5.0 to growth at pH 7.0. Experiments
were repeated at least three times and produced similar results,
and representative results are shown.
SENSITIVITY TO NICKEL SULFATE AND SODIUM AZIDE
To test Brucella sensitivity to heavy metal and respiratory chain
inhibitor, a previously described method was used with modi-
fication (Endley et al., 2001). Log phase bacteria, obtained after
24 h growth in E-medium pH 7.0, were serially diluted and plated
on TSA or TSA supplemented with 0.15mMNiSO4 and 0.15mM
NaN3. CFUwere counted after five days’ incubation. Experiments
were repeated at least three times, with similar results. Data from
a representative experiment are shown.
MEASUREMENT OF HYDROGEN PEROXIDE SENSITIVITY
To measure hydrogen peroxide sensitivity, a previously described
method was used (Elzer et al., 1994). Briefly, bacteria lawns from
exponential growth phase were made by plating 100μl Brucella
growing in E-medium pH 7.0 on TSA plates. A small sterile disk
of Whatman paper containing 5μl 30% H2O2 was placed in
the middle of each lawn. After five days’ incubation, the zone
of bacterial clearance was measured. Experiments were repeated
at least three times with triplicate plates. Results from a single
representative experiment are shown.
COMPLEMENTATION OF THE cydX MUTANT
In order to restore a functional copy of cydX in the mutant, a
previously described groEL promoter (Gor and Mayfield, 1992;
Lin et al., 1992) corresponding to Brucella abortus 2308 chro-
mosome II DNA coordinates 184149–184551 with engineered
restriction enzyme sites was amplified using primers GroEL-P-F
and GroEL-P-R and cloned into the pCR2.1 TOPO cloning vec-
tor. The insert was excised using SphI and NdeI and ligated into
broad host range cloning vector pFlagTEM1 (GeneBank acces-
sion number EU44730) (Raffatellu et al., 2005; Sun et al., 2007)
to replace lacIq and the trc promoter. cydX, cydB, and cydBX were
amplified from Brucella abortus 2308 genomic DNA, respectively,
cloned into TOPO vector and then introduced just downstream
of the groEL promoter using NdeI and PstI, to generate plasmids
pGroEL/CydX, pGroEL/CydB, and pGroEL/CydBX. To show
functionality of the GroEL promoter in B. abortus, a DsRed
gene, encoding a red fluorescent protein (Shaner et al., 2004),
was also cloned in the same way to generate pGroEL/dsRed. In
order to monitor CydX expression, a plasmid with a 3×FLAG tag
fused at the C terminus of CydX was constructed so that CydX
expression as a tagged protein could be conveniently detected
by using anti-FLAG monoclonal antibody (Sigma). Briefly, to
ensure 3×FLAG—tagged protein expression in Brucella, a pro-
moter demonstrated previously to be constitutively active under
in vitro growth conditions (Eskra et al., 2001), corresponding to
B. abortus 2308 chromosome II DNA coordinates 1045014 and
1045238 was amplified with primers Promoter-F and Promoter-
R. The 226 bp amplicon flanked by KpnI-HpaI and NdeI-SalI
was cloned into pCR2.1 TOPO vector and the orientation was
chosen in such a way that double digestion with SalI/SacI did
not excise the insert. 3×FLAG with two stop codons, amplified
from pSUB11 (Uzzau et al., 2001) using primer pair of Flag-F
and Flag-R, digested with SalI and SacI, was then ligated with
constitutive promoter PBMEII0192 in pCR2.1 TOPO vector. The
270 bp of “PBMEII0192-NdeI-SalI-3×Flag,” digested as KpnI/SacI
fragment, was inserted into the same sites of pBBR1MCS (Elzer
et al., 1994) to give rise to pBBR1Flag. Plasmid pCydX/Flag was
made by cloning cydX, which was amplified from the B. abortus
genome, TOPO-cloned into pCR2.1, and excised as NdeI/XhoI
fragment, into NdeI/SalI sites of pFlag (XhoI and SalI sites are
compatible). All constructs were confirmed by DNA sequenc-
ing to ensure correct insertion and/or in frame expression of
fusion proteins. All primers were used in this work are listed in
Table A1.
DETERMINING CydX LOCALIZATION AND ORIENTATION USING
β-LACTAMASE AS A REPORTER
pFlagTEM1 (Raffatellu et al., 2005; Sun et al., 2007) was used
to express β-lactamase fusions to CydX. To express 3×FLAG-
tagged β-lactamase as an fusion to the C-terminus of CydX
(CydX::TEM1) cydX from B. abortus 2308 was amplified with-
out STOP codon, inserted into pCR2.1 and excised as an NdeI
and SalI fragment. This fragment was then cloned into plasmid
pFlagTEM1 using NdeI and XhoI. Similarly, to fuse 3×FLAG-
tagged β-lactamase to theN terminus of CydX, cydXwas amplified
and cloned into pFlagTEM1 using XbaI and PstI to express
TEM1::CydX. Other fusions were made in the same way or have
been alreadydescribed (Table 1). All constructswere sequenced to
ensure in frame expression as Flag tagged TEM-1 fusion proteins.
Fresh bacteria growing on plates were resuspended in TSB.
Serial dilutions were made after OD600 was measured. 10μl of
bacteria containing about 103 CFU were spotted on TSA in 96-
well plates with 100μg/ml Carb, or 1mM IPTG plus 15μg/ml
Cm, or IPTG plus Carb which concentrations range from 0 to
1mg/ml. Plates were checked after five days’ incubation to deter-
mine bacterial viability. Survival was scored as the maximum
antibiotic concentration permitting growth of B. abortus.
SDS-PAGE ANDWESTERN BLOTTING
To measure expression of 3×FLAG-tagged or/and β-lactamase
fusion proteins, B. abortus was cultured in TSB at 37◦C with
shaking at 200 rpm. After 18 h the OD600 of the cultures ranged
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from 1.2 to 1.5 and bacteria were pelleted and resuspended in
1X Laemmli sample buffer, heated at 100◦C for 5min, and the
total protein equivalent to 1 × 108 CFU loaded per well was then
electrophoresed on a 12–15% polyacrylamide gel and transferred
to nitrocellulose membrane. Membranes were blocked in 2%
non-fat skim milk in PBS for an hour and then probed with Anti-
FLAG Monoclonal antibody (1:5000, Sigma) or anti-β-lactamase
monoclonal antibody (1:5000, QED Bioscience Inc.). Primary
antibody binding was detected using a goat-anti-mouse anti-
body conjugated to horseradish peroxidase (HRP). HRP activity
was detected with a chemiluminescent substrate (NEN). A previ-
ously described polyclonal antibody against the B. abortus protein
Bcsp31 was used as a loading control (Sun et al., 2005).
RESULTS AND DISCUSSION
TARGETED MUTAGENESIS OF SMALL HYPOTHETICAL ORFs
Using the published genome sequences of B. abortus 2308, B. suis
1330, and B. melitensis 16M, we identified ORFs with the poten-
tial to encode proteins smaller than 15 kDa. Thirty of these ORFS
were selected for mutagenesis based on having no predicted func-
tion and lack of annotation in the genome of A. tumefaciens
C58. Some of these proteins were assigned families of conserved
proteins such as clusters of orthologous genes (COG) with only
general functional predictions or families containing conserved
domains of unknown function (DUF). Precise deletions of each
ORF were constructed and marked with a kanamycin resistance
gene (Tables 1, 2). Mutations were confirmed by PCR, and/or by
Southern blot using probes specific to the deleted gene. For 30
genes we could confirm inactivation (See Figure A1 for details of
the mutagenesis procedure).
MUTANTS BAB2_0726, BAB2_0470, AND BAB2_0450 ARE HIGHLY
ATTENUATED BOTH IN CULTURED MACROPHAGES IN VITRO
AND IN A MOUSE MODEL IN VIVO.
In order to determine whether any of the genes inactivated in the
collection of mutants were required for intracellular survival we
tested the ability of 30 mutants to survive and replicate for 48 h
within cells of the macrophage-like line J774. All the mutants had
similar growth rates as wild type B. abortus when growing in TSB
(data not shown). Three mutants, BAB2_0726, BAB2_0470, and
BAB2_0450 exhibited marked intracellular growth defects in a
competitive infection against wild type in J774 macrophage-like
cells (Table 2). Macrophage infection experiments were repeated
with individual mutants (non-competitive infection) and exhib-
ited the same attenuation phenotype as in mixed infection. After
48 h infection, the intracellular CFU of mutants BAB2_0726,
BAB2_0470, and BAB2_0450 was decreased 2–3 orders of magni-
tude compared with wild type although they were less attenuated
than ADH3 (virB2), a mutant defective in the type IV secretion
system (den Hartigh et al., 2004) (Table 2).
We also investigated the role of these small hypothetical
genes in persistent infection in a mouse model. To minimize
the variation caused by different inoculum doses, we conducted
competitive infection experiments, in which we inoculated mice
IP with a 1:1 mixture of each mutant with wild type B. abor-
tus 2308. Four weeks after inoculation, bacterial load in spleens
were determined by differential plating on TSA with or without
kanamycin and the competitive index was calculated as CFU of
mutants/CFU of wild type and corrected for mutant/wild type
ratio in each inoculum. Most of the mutants were recovered in a
number similar to the wild type from the spleen of infected mice,
suggesting that these mutants have equal ability to persist for up
to four weeks. However, three mutants were attenuated compared
with wild type, having competitive indices ranging from 0.018
to 0.001. Consistent with the attenuation phenotype observed
in cultured mouse macrophages in vitro, mutants BAB2_0726,
BAB2_0470, and BAB2_0450 were highly attenuated in vivo
(Table 2). A fourth mutant, BAB1_0355, was found to be attenu-
ated in the in vivo competitive infection assay, but not in J774 cells
(Table 2). BAB1_0355 is related to LrgA of Staphylococcus aureus,
which encodes a regulator of murein hydrolase (Groicher et al.,
2000). BAB2_0450 is upstream of a predicted carbonic anhydrase,
which has been characterized as a target for anti-Brucella drugs
(Joseph et al., 2010), so its function may be related to that of the
carbonic anhydrase, or its deletion may have a polar effect on car-
bonic anyhdrase expression. BAB2_0470 belongs to a family of
proteins designated “S23 ribosomal proteins” which share simi-
larity to proteins of unknown function encoded by an intervening
sequence in the 23S ribosomal genes of Leptospira and Coxiella
burnetii (Ralph and McClelland, 1993; Afseth et al., 1995).
BAB2_0726 IS LOCATED IN THE 3′ END OF cyd OPERON AND THE
PHENOTYPE OF A DELETION MUTANT IS SIMILAR TO THAT OF
cydB MUTANTS
The in vitro and in vivo attenuation phenotypes of mutants
BAB2_0726, BAB2_0470, and BAB2_0450 raised the question
of how these small hypothetical proteins could contribute to
Brucella virulence. While analysis of BAB2_0470 and BAB2_0450
did not reveal any clues to their function, by looking the gene
organization of BAB2_0726 in Brucella abortus 2308 genome we
found that BAB2_0726 is located at the 3′ end of the cydAB
operon, a gene cluster encoding subunits of a high affinity termi-
nal oxidase of the oxygen respiratory chain (Endley et al., 2001)
(Figure 1A). This gene organization pattern is well conserved
in all sequenced Brucella genomes. The localization of a small
peptide downstream of cydB was also reported in Escherichia
coli, where it has been designated orfC or ybgT (Muller and
Webster, 1997; Hemm et al., 2010). This finding led us to
designate BAB2_0726 as cydX, since cydC (BAB2_0729) and
cydD (BAB2_0730) immediately upstream of cydA were already
assigned in E. coli to genes encoding a bacterial glutathione
transporter (Pittman et al., 2005).
Since based on in silico analysis, cydA, cydB, and cydX are
predicted to be transcribed together from a promoter upstream
of cydA, we determined whether insertional activation of cydB
would be polar on cydX expression (Figure 1B). To this end, RT-
PCR was performed to assay expression of cydA, cydB, and cydX
in B. abortus 2308 (WT) or an isogenic Tn5 insertion in cydB
(Endley et al., 2001). While a faint product for cydA was observed
in both WT and the cydBmutant, neither cydB nor cydX amplifi-
cation products were found in the cydBmutant, suggesting a polar
effect of the cydB mutation on cydX expression. These results
suggested that cydX is transcribed together with the cytochrome
bd oxidase subunits encoded by cydA and cydB.
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Table 2 | Small ORFs (<15kDa) with no assigned function, which are highly conserved in Brucella species.
B. abortus 2308 ORFa B. suis 1330 ORFa B. melitensis 16M ORFa Annotationb In vitro CIc In vivo CId
BAB2_0068e BRA0069 BMEII0025 Type IV secretion system protein
virB1
0.0023 0.0001
BAB1_0061 BR0064 BMEI1881 hypothetical protein 0.7493 1.2039
BAB1_0355 BR0325 BMEI1597 COG1380 LrgA family protein
[general function prediction
only]
1.3655 0.0153
BAB1_0513 BR0488 BMEI1447 hypothetical protein 5.6537 1.0448
BAB1_0581 BR0557 BMEI1376 COG3654; prophage maintenance
system killer protein [general
function prediction only]
1.8387 0.5577
BAB1_0626 BR0602 BMEI1339 hypothetical protein 3.6877 N
BAB1_0743 BR0725 BMEI1227 hypothetical protein [possible
relationship to
acetyltransferases]
0.6340 0.6160
BAB1_0992 BR0973 BMEI1005 hypothetical protein 1.1191 0.4853
BAB1_1106 BR1083 BMEI0899 COG3617; prophage antirepressor
[possible function in
transcription]
1.2815 0.6963
BAB1_1194 BR1173 BMEI0813 hypothetical protein 1.2322 0.3799
BAB1_1204 BR1181 BMEI0806 hypothetical protein 1.3258 0.4248
BAB1_1262 BR1241 BMEI0751 hypothetical protein N 1.5608
BAB1_1390 BR1370 BMEI0633 COG0239; possible integral
membrane protein
N 1.8630
BAB1_1392 BR1372 BMEI0631 COG3467; predicted flavin
nucleotide binding protein
[general function prediction
only]
N 1.4038
BAB1_1743 BR1730 BMEI0308 hypothetical protein 0.6744 N
BAB1_1748 BR1736 BMEI0304 COG1607, Acyl-CoA hydrolase
[Lipid metabolism]
N 1.3140
BAB1_1939 BR1938 BMEI0127 hypothetical protein 0.4634 0.4569
BAB1_2041 BR2041 BMEI0030 DUF188superfamily 2.6421 0.5280
BAB2_0160 BRA0162 BMEII1078 COG4893; uncharacterized
protein conserved in bacteria
0.6152 1.1670
BAB2_0170 BRA0175 BMEII1067 DUF465superfamily; putative
cytosolic protein
0.2584 N
BAB2_0761 BRA0476 BMEII0789 hypothetical protein 0.5177 N
BAB2_0726 BRA0512 BMEII0758 Pfam01873; YbgT-like protein 0.0079 0.0001
BAB2_0470 BRA0769 BMEII0522 Pfam05635; family of hypothetical
proteins
0.0002 0.0025
BAB2_0450 BRA0787 BMEII0503 hypothetical protein 0.0435 0.0180
BAB2_0415 BRA0819 BMEII0468 hypothetical protein 1.0595 1.2254
BAB2_0400 BRA0836 BMEII0454 hypothetical protein 1.0501 1.8400
BAB2_0232 BRA1000 BMEII0296 hypothetical protein N 0.9205
BAB2_1072 BRA1113 BMEII0186 pemK family protein [possible
regulator]
5.1792 0.5605
BAB2_1087 BRA1130 BMEII0169 Hypothetical protein [flagellar
locus]
N 1.0841
BAB2_1136 BRA1177 BMEII0118 DUF1634superfamily 0.2300 0.4828
aORF number from NCBI.
bFollowed B. suis 1330 assignment.
cCompetitive index (CI): Calculated as Mean Mutants/WT from at least three experiments. N: Not tested.
dCompetitive index (CI): Calculated as Mean Mutants/WT in spleen of 2–5 mice. N: Not tested.
eA previously characterized virB1 mutant (BA41) serves as attenuation phenotype control.
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FIGURE 1 | cydA, cydB, and cydX are organized and transcribed as a
gene cluster. (A) Genetic map of the cyd locus in B. abortus 2308
chromosome II. cydA and cydB encode two proteins with similarity to subunit
I and II of cytochrome bd-1 terminal oxidase in E. coli. Upstream of cydA and
cydB are two predicted ABC transporter genes with similarity to E. coli cydD
and cydC. Overlapping 23 bp with cydB, cydX encodes a 64 aa protein with
one predicted transmembrane domain (shaded), spanning residues 17–35.
While no promoter is predicted in front of cydD there is a promoter (PcydAB),
possibly driving transcription of cydA, cydB, and cydX. A transcriptional
terminator (circled T) is located between cydX and its adjacent open reading
frame BAB2_0725. In BA582 (cydB::Tn5) a transposon is inserted in cydB
(triangle) while in cydX ::Kan part of cydX (hatched) is replaced by a
kanamycin resistance determinant without disrupting cydB. (B) Analysis of
the cyd gene cluster by RT-PCR. PCR products for the indicated primers with
wild type (WT) or cydB::Tn5 mutant (BA582) as a template are shown. The
sizes of the predicted amplicons for cydA, cydB, and cydX are 247 bp,
243 bp, and 204 bp, respectively. Control reactions in which reverse
transcriptase were omitted had no amplification product (not shown).
To determine whether CydX is functionally related to
cytochrome bd oxidase, we determined whether deletion of cydX
affects stationary phase viability, a phenotype that is defective
in a B. abortus cydB mutant (Endley et al., 2001). As shown
in Figure 2A, when grown in minimum medium with starting
OD600 = 0.05 all Brucella strains replicated equally until they
reached stationary phase (48–72 h). However, similar to the
cydB mutant BA582, the viability of the mutant deleted for cydX
declined rapidly as the incubation time progressed, while wild
type B. abortus survived for up to five days. Similar results were
observed when the mutants were grown in rich medium (TSB)
(data not shown). Our finding that deletion of cydX impaired
intracellular growth (Table 2) and led to loss of viability in sta-
tionary phase (Figure 2A) prompted us to determine whether
this mutant shared other defects associated with inactivation of
cytochrome bd oxidase (Endley et al., 2001). Similar to a cydB
mutant, the B. abortusmutant lacking cydX exhibited significantly
(P < 0.01) increased sensitivity to hydrogen peroxide compared
with wild type B. abortus (Figures 2C,D).
Disruption of cytochrome bd oxidase increases sensitivity to
the respiratory chain inhibitor sodium azide and the uncou-
pling agent nickel in both Brucella and E. coli (Wall et al., 1992;
Edwards et al., 2000; Endley et al., 2001). Similarly to the B. abor-
tus cydB mutant, the mutant lacking cydX was highly sensitive to
the combination of sodium azide plus nickel sulfate, compared
to wild type B. abortus (Figure 2E). The data suggested that the
small protein CydX is required for the function of cytochrome bd
oxidase in B. abortus.
COMPLEMENTATION OF THE CYDX MUTANT LEADS TO PARTIAL
RESTORATION OF CYD PHENOTYPES AND IMPROVES INTRACELLULAR
GROWTH IN MOUSE MACROPHAGES.
To confirm that the phenotypes of the cydX::Kan mutant result
from deletion of cydX, we conducted complementation experi-
ments to satisfy the molecular Koch’s postulates (Falkow, 1988).
To this end, constructs encoding either CydX or CydX::3×-FLAG
were generated. The groEL promoter, known to be induced dur-
ing growth in macrophages (Lin and Ficht, 1995), was used
to drive cydX expression. As a control for the expression of
cydX, we expressed the gene encoding the fluorescent protein
DsRed from the same promoter and confirmed fluorescence of
the recombinant strain (not shown). Immunoblot analysis of
Brucella expressing CydX::FLAG with anti-Flag antibody revealed
a major band of 10 kDa, a size matching the predicted size of
CydX (8 kDa) and 3×FLAG (2 kDa), indicating that CydX is
indeed expressed as protein in Brucella (not shown). Both the
cydX mutant and BA582 (cydB::Tn5) were transformed with con-
structs expressing cydX, cydB, or cydBX to determine whether
the phenotypes associated with cytochrome bd oxidase deficiency
could be complemented (Figure 3). Complementation of both
cydB and cydX mutants with their respective genes restored sta-
tionary phase viability (Figure 3A), and complementation of
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FIGURE 2 | Characterization of the cydX mutant. (A) Loss of viability in
stationary phase. Growth kinetics of B. abortus in modified E medium pH
7.0 was monitored by CFU counting at each indicated time point. Each data
point represents results of a single assay that was repeated twice.
(B) Intracellular survival of the cydX mutant in J774 macrophages. Strain
ADH3 (virB2) served as an attenuated control. Data are represented as the
mean ± standard deviation (SD) of triplicate samples from one assay that
was repeated twice with the same result. Significance of differences was
analyzed by One-Way analysis of variance (ANOVA), with a P value of less
than 0.05 considered as significant. The dotted line indicates the limit of
detection. (C and D) Sensitivity to hydrogen peroxide. Log-phase bacteria
were plated on TSA and oxidative killing was determined by measuring the
diameter of clear zone surrounding a paper disk soaked with 5μl of 30%
hydrogen peroxide. Large zones of bacterial growth inhibition were
observed in both cydX and cydB mutants (Typical photographs were
shown). Data in (D) are represented as means of a single assay with five
samples ± SD, that was repeated once with the same result. Significance
of differences was analyzed by One-Way ANOVA, with P values for
pairwise comparisons with P < 0.05 indicated. (E) Sensitivity to sodium
azide plus nickel sulfate. Log-phase bacteria growing TSA or TSA
supplemented with 0.15mM NiSO4 and 0.15mM NaN3 were serially
diluted and were plated on TSA for enumeration of surviving bacteria.
Survival of treatment with sodium azide plus nickel sulfate was calculated
as the ratio of CFU on TSA + NiSO4 /NaN3 to CFU on TSA. While these
ratios were approximately 1 for wild type B. abortus, neither cydX mutant
nor the cydB mutant survived in the presence of these chemicals. A dotted
line indicates the limit of detection of this assay.
this phenotype in the cydX mutant was unaffected by addition
of the 3X-FLAG tag to the C terminus of CydX. As expected,
the construct expressing DsRed failed to complement the cydX
mutant since it expressed an irrelevant control protein.
Complementation of hydrogen peroxide sensitivity in the
cydX mutant was also observed with constructs expressing CydX
FIGURE 3 | Complementation of cydX mutation. Plasmid-encoded
copies of cydB or cydBX, cydX or cydX-FLAG were introduced into cydX
and cydB mutants. A plasmid expressing DsRed served as a negative
control. (A) Restoration of stationary phase viability was determined as
decribed in Figure 2. (B) Sensitivity to 3% Hydrogen peroxide was assayed
as described in Figure 2. Significance of differences was analyzed by
One-Way ANOVA, with P values for pairwise comparisons with P < 0.05
indicated. (C) Sensitivity to sodium azide plus nickel sulfate was assayed as
described in Figure 2. (D) Sensitivity to acid pH. Viability of cultures
incubated for 5 h in E-medium adjusted to pH 7.0 or pH 3.5 was assayed as
described in the Materials and Methods. Each data point represents results
of a single assay that was repeated twice. (E) Survival in J774 mouse
macrophages. J774 cells were infected with cydX or cydB mutants
containing indicated plasmids. Cells were lysed at 24 and 48h
post-infection. Bacterial CFU were determined by serial dilution and plating
on TSA. Data represent the mean of triplicate samples ±SD from a single
experiment of three replicates with similar results. Significance of
differences was analyzed by One-Way ANOVA, with P values for pairwise
comparisons with P < 0.05 indicated. Dotted lines indicate the limit of
detection.
or CydX::Flag, as evidenced by the reduced zone of clearance
around filter disks containing hydrogen peroxide (Figure 3B).
Introduction of a construct encoding cydBX into the cydBmutant
(BA582) resulted in greater resistance to H2O2 compared to
introduction of a construct encoding cydB only (Figure 3B). This
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result suggested that the Tn5 insertion in cydB in BA582 could
have a polar effect on expression of cydX.
A second phenotype of the cydX mutant, lack of growth in the
presence of nickel and azide, was also complemented to the wild
type level by introduction of an intact copy of cydX or cydX::3x-
Flag, similar to what was observed for complementation of the
cydBmutant (Figure 3C).
Two cydX mutant phenotypes, sensitivity to acidic conditions
and intracellular survival in J774 macrophages, were only par-
tially complemented by introduction of constructs expressing
CydX or CydX::FLAG (Figures 3D,E). In the experiment shown
in Figure 3E, there were no remarkable differences between
CydX mutant transformed with pGroEL/dsRed, pGroEL/CydX,
or pCydX/Flag at 24 h post-infection. However, at 48 h post-
infection, the CFU recovered for mutants complemented with
CydX or CydX::Flag were markedly higher than that of mutant
transformed with pGroEL/dsRed (control). Complementation of
the cydXmutant with constructs expressing CydX or CydX::FLAG
resulted in partial restoration of intracellular survival, with a net
increase in bacterial numbers between 24 and 48 h. In contrast,
the cydX mutant complemented with the DsRed-expressing con-
struct failed to replicate during this time and actually decreased in
numbers. Based on this observation we concluded that the intra-
cellular growth defect of cydX mutant with impaired cytochrome
bd oxidase activity could be partially rescued by providing
wild type CydX or CydX::FLAG in trans. Interestingly, expres-
sion of cydX together with cydB increased survival of the cydB
mutantmore then complementation with cydB alone (Figure 3E).
However, expression of cydX alone in the same copy number
did not completely restore intracellular replication of the cydX
mutant.
It was of interest that while some phenotypes of the cydX
mutant, such as sensitivity to H2O2 or nickel sulfate/sodium
azide, could be complemented to the level of the wild type,
survival of pH 3.5 or intracellular replication of the cydX mutant
were restored to a lesser degree. It is possible that these two former
phenotypes require only some degree of cytochrome bd oxidase
activity, whereas intracellular growth and acid resistance repre-
sent stress conditions that may require either precise regulation of
cydABX expression or specific ratios of CydX to CydA and CydB.
Since CydX is predicted to be an integral cytoplasmic protein (see
below), it is conceivable that free CydX that is not associated with
a cytochrome bd oxidase complex might insert into the cytoplas-
mic membrane and destabilize other cell envelope functions that
are essential for resistance to acidic pH and intracellular replica-
tion. Our finding that expression of cydX in a cydBmutant lacking
cytochrome bd oxidase actually decreased stationary survival
(Figure 3A) is consistent with this interpretation.
THE C TERMINUS OF CydX IS LOCATED IN THE PERIPLASM
CydX is predicted to have a single transmembrane domain of 15–
17 residues. Since components of cytochrome bd oxidase in E. coli
are located at the cytoplasmic membrane (Miller and Gennis,
1983; Green et al., 1984; Miller et al., 1988) we hypothesized that
CydX could mediate its function by colocalizing with CydAB at
the cytoplasmic membrane, where it might serve to tether the
enzymatic components of the oxidase. To test this hypothesis, we
performed membrane fractionation of B. abortus, which failed
to yield a cytoplasmic membrane fraction of sufficient purity to
give conclusive results (data not shown). As a second approach
we constructed N- and C-terminal fusions of CydX to TEM-1
β-lactamase (Zhang et al., 2004) to determine the topology of
CydX in the cytoplasmic membrane. To this end, we designed two
constructs by cloning cydX in front or behind TEM-1 β-lactamase
(Datta and Kontomichalou, 1965) with a 3×FLAG epitope replac-
ing the TEM-1 signal sequence. Both constructs of pCydX/FT (FT
stands for 3×FLAG::TEM1) and pFT/CydX were DNA sequenced
to ensure in-frame expression of Cyd::FT or FT::CydX fusions.
FIGURE 4 | The C-terminus of CydX is located in the periplasm of
B. abortus. (A) Western Blot showing expression levels of β-lactamase
fusions to CydX and Glutathione-S-transferase (GST; a cytoplasmic control).
Blots were probed with a monoclonal antibody against TEM-1 β-lactamase
(right blot). As a loading control, the B. abortus protein Bcsp31 detected
using a polyclonal antibody (shown on the left) [Sun et al. (2005)].
(B) Maximum concentration of carbenicillin allowing growth of B. abortus
expressing each β-lactamase fusion protein. Plasmid pBBR1mcs4 is a
positive control that expresses β-lactamase resistance. pFlagTEM1 is the
plasmid carrying TEM-1 β-lactamase lacking its N-terminal sequence and was
used for generating N- and C-terminal fusions to CydX and GST. (C) Proposed
topological model for CydX in Brucella based on current understanding of
cytochrome bd quinol oxidase in E. coli and predicted single transmembrane
domain (shaded area) in CydX protein sequence.
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Since β-lactamase only confers resistance to β-lactam antibiotics
if it localizes to the periplasm, we could conclude based on ampi-
cillin resistance of each recombinant strain whether the TEM-1
domain was localized in the periplasm. As a control for a resi-
dent cytosolic protein we constructed a Glutathione S-transferase
(GST) β-lactamase fusions. The GST constructs and pFlagTEM1,
which is the empty vector to make CydX β-lactamase fusions,
were used as negative controls. As a positive control we used
pBBR1MCS4, which encodes β-lactam resistance. Expression of
CydX::FT allowed Brucella to survive a concentration of up to
250μg/ml, of carbenicillin, a maximal concentration similar to
that of positive control pBBR1MCS4, whereas the other strains
tested were sensitive to 20μg/ml of carbenicillin (Figure 4A).
This result indicated that the β-lactamase moiety of CydX::FT
was located in the periplasm, while in FT::CydX, TEM-1 was
retained in the cytoplasm. To exclude the possibility that the
carbenicillin sensitivity was due to low or absent expression of
β-lactamase fusions in those strains, we performed immunoblot
analysis of bacterial lysates using a monoclonal antibody spe-
cific to TEM-1 β-lactamase (QED Bioscience Inc.). High levels
of β-lactamase fusion protein expression were detected in all but
the pBBR1MCS4 transformed Brucella, which could be attributed
to the lower expression from a normal promoter, compared to
the IPTG inducible trc promoter in the other constructs, since
the TEM-1 constructs share identical sequences to the bla gene in
pBBR1MCS4 (Figure 4A). Based on our current understanding
about cytochrome bd oxidase in other organisms we predict that
Brucella CydX is inserted in cytoplasmic membrane, with its N
terminus at the cytosolic face and C terminus in the periplasm, as
depicted in Figure 4B.
In conclusion, we have identified a small protein, CydX
(BAB2_0726) that is co-regulated with CydAB, and is required
for full function of cytochrome bd oxidase in B. abortus. This
terminal oxidase is used by Brucella spp. to survive inside
eukaryotic cells, where it contributes to intracellular replica-
tion (Endley et al., 2001; Loisel-Meyer et al., 2005; Wu et al.,
2006). Interestingly, in contrast to B. abortus, in which cydB
mutants were highly attenuated, B. suis cydBmutants were hyper-
virulent, suggesting different use of terminal oxidases in these
two species (Jimenez de Bagues et al., 2007). Additional evi-
dence for CydX expression during in vitro growth of B. abortus
was recently provided by a proteomic study (Lamontagne et al.,
2010). The requirement of CydX for cytochrome bd oxidase func-
tion may be shared with other bacteria expressing cytochrome
bd oxidase, such as E. coli and S. Typhimurium, since a small
protein YbgT was identified downstream of the cydB gene in
these two organisms (Alix and Blanc-Potard, 2009; Hemm et al.,
2010). In E. coli, cytochrome bd-I oxidase was shown to assem-
ble into large respiratory domains in the cytoplasmic membrane
(Lenn et al., 2008), so the insertion of CydX into the cytoplas-
mic membrane suggests that it might play a role in organizing
these complexes at the cytosolic face of the cytoplasmic mem-
brane or might be required for their terminal oxidase activity.
Further experimentation will be needed to determine the precise
mechanism by which CydX contributes to cytochrome bd oxidase
function.
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APPENDIX
FIGURE A1 | Strategy for Allelic Exchange Mutagenesis. See Materials and Methods for explanation.
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Table A1 | Primers used in this work.
Primer Sequence* Description
GBRORF0459 DN-F TCCCCCGGGAAAATAATTGACCATGGC
BAB1_0061GBRORF0459 DN-R AACTGCAGGGGCAGGCCCGCCGCCT
GBRORF0459 UP-F GTGCACCGCATTTATTGCGT
GBRORF0459 UP-R TCCCCCGGGTTGCAGATCAAAGAGCG
GBRORF0206 DN-F TCCCCCGGGAGCCTGCGTTATGCTGCCCGG
BAB1_0355GBRORF0206 DN-R AAACTGCAGCACCACGAAAATGGCCGTG
GBRORF0206 UP-F GCAGGCGCTCAAAATAATGTG
GBRORF0206 UP-R TCCCCCGGGCTTTGCGGGGGGCGTTCA
GBRORF0049 DN-F TCCCCCGGGATAGGTGTGCGCCCCGC
BAB1_0513GBRORF0049 DN-R AACTGCAGAAGTCGAATCCGCCCTC
GBRORF0049 UP-F CCGGCCTTCATGAGCCGGAT
GBRORF0049 UP-R TCCCCCGGGTCGTTTTGCGGGCCAAC
GBRORF2128 DN-F TCCCCCGGGCCGTTGTTATAAACGACGAC
BAB1_0581GBRORF2128 DN-R AAACTGCAGAGCTTTTACCAAAGAACAGG
GBRORF2128 UP-F GGCTCATACCCGCCAAATGCA
GBRORF2128 UP-R TCCCCCGGGTTCAGCCGTTCCAGCACTT
GBRORF2083 DN-F TCCCCCGGGAGAAGAAACTGTTGTT
BAB1_0626GBRORF2083 DN-R AAACTGCAGGTCCTTGTCGTCTTCAACA
GBRORF2083 UP-F CTGCTCAGATCGCCGGATGGC
GBRORF2083 UP-R TCCCCCGGGATTTATTGGCTGTCATATTGTT
GBRORF1960 DN-F TCCCCCGGGACGACCTGCTTTCGCAGAT
BAB1_0743GBRORF1960 DN-R AAACTGCAGCCCGTATGTAACAATGAG
GBRORF1960 UP-F CCTATGCAGCTTCCACCATTG
GBRORF1960 UP-R TCCCCCGGGTAAGTTTGTGTGCTCATTC
GBRORF1747 DN-F TCCCCCGGGCTATCCCGCGACGAGCG
BAB1_0960GBRORF1747 DN-R AAACTGCAGAAGCTGATCTTCATCGAT
GBRORF1747 UP-F GATAGTGCCAGGATAAGGAAA
GBRORF1747 UP-R TCCCCCGGGATGGAAAACTTCATCATT
GBRORF1716 DN-F TCCCCCGGGTCAAGAAATTCAACCTT
BAB1_0992GBRORF1716 DN-R AACTGCAGATCGCCTGATGGCAATC
GBRORF1716 UP-F TCCGATTGGGCGTAGCTTAC
GBRORF1716 UP-R TCCCCCGGGTACTGGCGCTGGCGTCT
GBRORF1608 DN-F TCCCCCGGGACGCTCATCACCTTGACGGA
BAB1_1106GBRORF1608 DN-R AAACTGCAGCCCTCCCGCCCCTCACGT
GBRORF1608 UP-F GGCGAGAGGGATGAAGATCGA
GBRORF1608 UP-R TCCCCCGGGTCCATGAAGTTGAAGATTT
GBRORF1520 DN-F TCCCCCGGGCGATTCCATTAAAACAG
BAB1_1194GBRORF1520 DN-R AACTGCAGAATCATGGCTCTAAATC
GBRORF1520 UP-F CCTTGGCATGGCGCTGCGTC
GBRORF1520 UP-R TCCCCCGGGCCTGTCCTTCGCTCGGG
GBRORF1512 DN-F TCCCCCGGGCGTTGCCGTCGGCCATAG
BAB1_1204GBRORF1512 DN-R AACTGCAGCCTGCGGTCCATTCGTA
GBRORF1512 UP-F GTTGTGCTACTTCATTTACG
GBRORF1512 UP-R TCCCCCGGGTCGCCGCACCGCCTG
GBRORF1452 DN-F TCCCCCGGGCGACGACGAAGAGGAAGAG
BAB1_1262GBRORF1452 DN-R AAACTGCAGACGCCTTCGTTCATCT
GBRORF1452 UP-F CAGTGCAGGAACCTTATTGCG
GBRORF1452 UP-R TCCCCCGGGACTCGGATGTGCTTCAATAGC
GBRORF1325 DN-F TCCCCCGGGTTTGCCGCATGGCTCGACGC
BAB1_1390GBRORF1325 DN-R AAACTGCAGCGACGGAGTGGCGGCTCT
(Continued)
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Table A1 | Continued
Primer Sequence* Description
GBRORF1325 UP-F GGCCAGATAGCCCGGAACGA
GBRORF1325 UP-R TCCCCCGGGACCCACATAACATCTAAAGGA
GBRORF1323 DN-F TCCCCCGGGCATCAGGCGGAGTGACC
BAB1_1392GBRORF1323 DN-R AAACTGCAGGACGTCGGCCTCCATTCTC
GBRORF1323 UP-F GCTTGTGACGCTGGAGGAAAA
GBRORF1323 UP-R TCCCCCGGGTCCGACATTTCCGTTATCAAC
GBRORF0969 DN-F ACCCCGGGCTTTCACCTGCACGAAG
BAB1_1743GBRORF0969 DN-R ACCTGCAGACCTATGGCGTGGATTCG
GBRORF0969 UP-F ACGCGCGATGGCTCAATGC
GBRORF0969 UP-R ACCCCGGGCAGGATTTTGGTCAC
GBRORF0964 DN-F TCCCCCGGGTATCCCCATCGAGCTTGCC
BAB1_1748GBRORF0964 DN-R AAACTGCAGGATCGCCCGAATGCGATT
GBRORF0964 UP-F CCGACACCCAGATTCATGCGC
GBRORF0964 UP-R TCCCCCGGGTTCTTGAAAACGTCTTTCATG
GBRORF0765 DN-F TCCCCCGGGTTGATGTCCTTCAATTC
BAB1_1939GBRORF0765 DN-R AACTGCAGGATGCGCCAGACGAA
GBRORF0765 UP-F ACGGCGCATGCTTCTTGTCG
GBRORF0765 UP-R TCCCCCGGGGGGCTGGTTCGGACAAT
GBRORF0663 DN-F TCCCCCGGGCAATACGTTCCGGCGAAG
BAB1_2041GBRORF0663 DN-R AACTGCAGGTGTCGAGAAGCTCAAG
GBRORF0663 UP-F CCTGCATCTGCAAAGGCC
GBRORF0663 UP-R TCCCCCGGGTGGTTGATGCCATCATT
GBRORFA0247 DN-F TCCCCCGGGTGTGCGCGGCCAAGATAA
BAB2_0160GBRORFA0247 DN-R AAACTGCAGCCCTGCAAAATTTCCTGT
GBRORFA0247 UP-F CCATGGGTATGATGATGCTGC
GBRORFA0247 UP-R TCCCCCGGGTTTCCCGCAAGCTGCAAGC
GBRORFA0258 DN-F TCCCCCGGGCGCTTGCCGCCGCCTGATT
BAB2_0170GBRORFA0258 DN-R AAACTGCAGATTGGTGAGGGGGCGAAA
GBRORFA0258 UP-F CCGCTTCGTCGAACAGGCAAC
GBRORFA0258 UP-R TCCCCCGGGGCGTATTCGACATTCTAC
GBRORFA1086 DN-F TCCCCCGGGCTTTCCATCGCCTGAAACTGT
BAB2_0232GBRORFA1086 DN-R AAACTGCAGGGGAAATGTAGGAGGTAG
GBRORFA1086 UP-F GAAGAAGGCCTTATCTGATCA
GBRORFA1086 UP-R TCCCCCGGGCCGCCCCCTCTTCACCATGA
GBRORFA0924 DN-F TCCCCCGGGTGGAACACTCTCCCTGC
BAB2_0400GBRORFA0924 DN-R AACTGCAGTCCTTTGCTGCCTTTGT
GBRORFA0924 UP-F GCGTATCAGCCATGCAGGCG
GBRORFA0924 UP-R TCCCCCGGGTAAGACGTAGGTTAGGC
GBRORFA0907 DN-F TCCCCCGGGCAGCAATGGTTCGACGAAAG
BAB2_0415GBRORFA0907 DN-R AAACTGCAGACAAATGCACCGAGGAT
GBRORFA0907 UP-F GCGGATCGGCGAGACTTTTCC
GBRORFA0907 UP-R TCCCCCGGGCAGTTCCATGACCCGTTCT
GBRORFA0873 DN-F TCCCCCGGGCGCTTCCCGCCTACTACTGA
BAB2_0450GBRORFA0873 DN-R AAACTGCAGCCATAATGTCCGCAAAC
GBRORFA0873 UP-F GGTTTTGCAGTGGCTTCCAG
GBRORFA0873 UP-R TCCCCCGGGGGCAGCAAACTGGACATT
GBRORFA0854 DN-F TCCCCCGGGCTTCTCATCCGCAAGCTA
BAB2_0470GBRORFA0854 DN-R AAACTGCAGATAGCGCGGCTTGTGCAC
GBRORFA0854 UP-F CATGTTCAAGCGCACGATCCG
GBRORFA0854 UP-R TCCCCCGGGATATGAATTGATTGACATCAC
(Continued)
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Table A1 | Continued
Primer Sequence* Description
GBRORFA0598 DN-F TCCCCCGGGCAACAAGCACCACTGAAATG
BAB2_0726GBRORFA0598 DN-R AAACTGCAGATATGGCCCGGCGCGGCAT
GBRORFA0598 UP-F CGGCGGCTTCGTGCCGGCGC
GBRORFA0598 UP-R TCCCCCGGGTTGCTCTCATCCTCGATCA
GBRORFA0563 DN-F TCCCCCGGGCCTATGCAGAAGCCCTG
BAB2_0761GBRORFA0563 DN-R AACTGCAGAAGAGAATATGGCCGTC
GBRORFA0563 UP-F CGCTTTTTCCCGGCAGCATG
GBRORFA0563 UP-R TCCCCCGGGTTCGGTTTCAGTTTCTC
GBRORFA0429 DN-F TCCCCCGGGCTGAAGCAGAACTCAAGAAAGTT
BAB2_0862GBRORFA0429 DN-R AAACTGCAGTTTAATGAGATATTTC
GBRORFA0429 UP-F CAATGCAGGCGCAATTGCAAC
GBRORFA0429 UP-R TCCCCCGGGAAGAGAGCCTTAATCATTTCC
GBRORFA1199 DN-F TCCCCCGGGTTCCCGTTTCTGCGACG
BAB2_1072GBRORFA1199 DN-R AAACTGCAGATAACGGCATCAGCACCG
GBRORFA1199 UP-F GGGCACTTCTTCTGCCACGT
GBRORFA1199 UP-R TCCCCCGGGATAGTTTCGGCTTCGAT
GBRORFA0014 DN-F TCCCCCGGGATGAGTCGCAAAAGCGGAG
BAB2_1087GBRORFA0014 DN-R AAACTGCAGGGTTGCCGGCGCCTCTG
GBRORFA0014 UP-F GGCCGCCGTGCTGGCGTTTTG
GBRORFA0014 UP-R TCCCCCGGGCGTGTTCCAGCCTGCGTCAT
GBRORFA0062 DN-F TCCCCCGGGTAGGCTTATCCAGGCTGTA
BAB2_1136GBRORFA0062 DN-R AAACTGCAGGCCTATGGTCTCTTCCCGG
GBRORFA0062 UP-F CCGCTTCTCACATCCATTTTC
GBRORFA0062 UP-R TCCCCCGGGCGATGCTGTTATCTTCGAT
GroEL-P-F AGCATGCCGTTCGGGCGATGGAAACAGGCGTG
Promoter PGroEL
GroEL-P-R ACATATGGTATAACCCTTGGTGTTATAGACG
dTomato-F ACATATGGTGAGCAAGGGCGAGGAGGTC
pGroEL/dsRed
dTomato-R ACCCGGGATGCATTACTTGTACAGCTCGTCCATGCCGTAC
A0598-Flag-F ACATATGAGAGCAACCACGCTTAC
pGroEL/CydX
A0598 -PstI ACTGCAGTCAGTGGTGCTTGTTGCCTTC
CydB-F-NdeI ACATATGATACTCAGCGATTTGTTGGACTATC
pGroEL/CydB
CydB-R-PstI ACTGCAGTCAGTAAGCGTGGTTGCTCTCATCCTC
CydB-F-NdeI ACATATGATACTCAGCGATTTGTTGGACTATC
pGroEL/CydBX
A0598 -PstI ACTGCAGTCAGTGGTGCTTGTTGCCTTC
A0598-Flag-F ACATATGAGAGCAACCACGCTTAC
pCydX/FT
A0598-Flag-R AGTCGACGTGGTGCTTGTTGCCTTC
A0598 -XbaI ATCTAGAAGAGCAACCACGCTTACTGATTG
pFT/CydX
A0598 -PstI ACTGCAGTCAGTGGTGCTTGTTGCCTTC
Promoter-F TTAGGGTACCGTTAACGCTCCCCGAAAACGGC
Promoter PBMEII0192Promoter-R AGTCGACATATGTGATTTCCGGC
Flag-F ACATATGAGCCTAGTCGACTACAAAGACCATGAC
pBBR1Flag
Flag-R AGAGCTCCTGCAGTTACTATTTATCGTCGTCATC
A0598-Flag-F ACATATGAGAGCAACCACGCTTAC
pCydX/Flag
A0598 -PstI ACTGCAGTCAGTGGTGCTTGTTGCCTTC
∗Engineered restriction sites underlined.
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